But in this case the mice carried human tumours - the drug effect was not on the mice, it was on the tumours. I think that is an important distinction.
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
NOX
noxopharm limited
Add to My Watchlist
27.1%
!
6.1¢

Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.1¢ |
Change
0.013(27.1%) |
Mkt cap ! $16.07M |
Open | High | Low | Value | Volume |
5.2¢ | 6.1¢ | 5.2¢ | $16.76K | 308.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 271477 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 523 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 271477 | 0.062 |
1 | 40845 | 0.056 |
1 | 10000 | 0.055 |
1 | 19607 | 0.051 |
2 | 220000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 523 | 1 |
0.071 | 14084 | 1 |
0.097 | 175845 | 1 |
0.098 | 186361 | 1 |
0.099 | 118494 | 1 |
Last trade - 12.15pm 16/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online